Bioneer A/S

Bioneer A/S is an innovative research-based non-for-profit organization with a history of more than 25 years. Bioneer is a subsidiary of the Technical University of Denmark. Since 2006, Bioneer has worked extensively on the development and implementation of applied stem cell technologies and stem cell focused platforms, within both multipotent and pluripotent stem cells. Bioneer has established a national iPSC core facility that operates in a variety of national and international research programs. Bioneer has developed and implemented iPSC platforms and genome editing technology (CRISPR/Cas) platforms and a variety of specialized differentiation protocols. Bioneer has extensive experience in developing and subsequent implementation of iPSC-derived disease and toxicity model systems to industry and the research community.

More information: »

In the initial EBiSC phase, Bioneer advised on validating the end-product, contributed with genome editing and disease modelling and was one of the key centres in charge of new cell line commissioning. In EBiSC2, Bioneer continues in its key role as coordinator of several proof-of-concept studies in differentiation and maturation.